Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol-assisted AFL-PDT for Actinic Keratosis
NCT02976727Phase 1Completed
- Sponsor
- Dong-A University
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AKP01 in actinic keratosis (AK) (2 arms), sponsored by Dong-A University. Primary endpoints: Short-term complete response rates at 3 months, Long-term complete response rates at 12 months and 1 more. Started May 2014; status: completed.
02
Drugs
AKP01
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02976727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976727.